Showing results (141-150 of 169) with videos related to

Sort By:
Pageof 17
Frontiers in Pharmacology|May 2, 2018
Inhibition of Streptococcus suis Adhesion and Biofilm Formation in Vitro by Water Extracts of Rhizoma CoptidisYan-Hua Li, Yong-Hui Zhou, Yong-Zhi Ren, et al.
Frontiers in Pharmacology|September 6, 2017
Comparative Proteomic Analysis Provides insight into the Key Proteins as Possible Targets Involved in Aspirin Inhibiting Biofilm Formation of Staphylococcus xylosusChang-Geng Xu, Yan-Bei Yang, Yong-Hui Zhou, et al.
Journal of Molecular Neuroscience : MN|September 17, 2014
The therapeutic potential of Rho kinase inhibitor fasudil derivative FaD-1 in experimental autoimmune encephalomyelitisYong-Fei Zhao, Xiang Zhang, Zhi-Bin Ding, et al.
CNS Neuroscience & Therapeutics|February 20, 2019
Nasal delivery of Fasudil-modified immune cells exhibits therapeutic potential in experimental autoimmune encephalomyelitisShang-De Guo, Chun-Yun Liu, Jing-Wen Yu, et al.
CNS Neuroscience & Therapeutics|September 22, 2012
Fasudil ameliorates disease progression in experimental autoimmune encephalomyelitis, acting possibly through antiinflammatory effectShao-Wei Hou, Chun-Yun Liu, Yan-Hua Li, et al.
European Journal of Immunology|October 8, 2014
Fasudil mediates cell therapy of EAE by immunomodulating encephalomyelitic T cells and macrophagesChun-Yun Liu, Shang-De Guo, Jie-Zhong Yu, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|October 27, 2017
[Relationship between cytoplasmic phospholipase A2 and nuclear factor κB in one lung ventilation-induced lung injury in rabbits]Yong Yang, Xin Guo, Zhi-Cheng Yu, et al.
Immunology|April 23, 2014
Intranasal delivery of FSD-C10, a novel Rho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitisYan-Hua Li, Jie-Zhong Yu, Chun-Yun Liu, et al.
Journal of Neuroinflammation|July 21, 2019
Mdivi-1, a mitochondrial fission inhibitor, modulates T helper cells and suppresses the development of experimental autoimmune encephalomyelitisYan-Hua Li, Fang Xu, Rodolfo Thome, et al.
Pathology, Research and Practice|July 1, 2019
PRKDC is a prognostic marker for poor survival in gastric cancer patients and regulates DNA damage responseYan Zhang, Guo-Ming Wen, Chuan-An Wu, et al.
Pageof 17